Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

gilead-sciences

Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says

May 15, 2019 Research and Development AIDS, BMS, Gilead, HIV, Janssen, generic drugs

Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for …
News
stormotion

Medical Affairs 2025 – Excellence in the era of precision medicine

May 15, 2019 Medical Communications, Research and Development pharma, veeva

Medical affairs is at the leading edge of a trend. As the life sciences industry shifts towards precision medicine, its …
News

Ex-GSK, Novartis exec named as Mundipharma’s Head of Access

May 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment, pharma

Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access. Moreau has amassed …
Appointment
sleeping-baby-1540295803spt

Prophylactic antibiotic use could halve post-birth maternal infections, study indicates

May 14, 2019 Manufacturing and Production, Research and Development Antibiotics, University of Oxford, pharma

A study led by researchers at the University of Oxford has argued that the administration of preventative antibiotics to all …
News
shutterstock_206748499

The interplay between the GDPR and the EU Clinical Trials Regulation

May 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, clinical trial data, clinical trials, eu clinical trials regulation, pharma, trial data

Paul Kavanagh, partner at law firm Dechert, explores the relationship between GDPR and CTR, and its potential impact on the …
Feature
fda2outsideweb

FDA to end controversial “alternative summary reporting” of medical devices in bid to boost transparency

May 10, 2019 Medical Communications, Research and Development, Sales and Marketing FDA, US, adverse events, medical devices, pharma

The FDA has revealed that it plans to terminate its “alternative summary reporting” programme which has allowed the manufacturers of …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, GSK, Innoviva, NHS, Novartis, health, migraine, pharma

This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving …
News

BMS blockbuster Opdivo falls short at Phase 3 in MGMT-unmethylated glioblastoma multiforme

May 10, 2019 Medical Communications, Research and Development BMS, Bristol-Myers Squibb, glioblastoma multiforme, pharma, trial failure

Bristol-Myers Squibb’s blockbuster immunotherapy Opdivo (nivolumab) has hit a hurdle, failing its primary endpoint in a Phase 3 trial investigating …
News
5204602349_c87b204860_z

Common diabetes drugs have been linked to a ‘flesh-eating’ genital infection

May 9, 2019 Medical Communications, Research and Development FG, diabetes, gangrene, health, necrotizing fasciitis

Patients taking some newer diabetes medications – SGLT2 inhibitors – have been warned that they may be at risk of …
News

Pfizer scores conditional European approval in ALK-positive lung cancer with Lorviqua

May 8, 2019 Research and Development Cancer, Europe, Lorviqua, NSCLC, Pfizer, lung cancer, pharma

Pfizer’s Lorviqua (lorlatinib), or Lorbrena as it is known in the US, Canada and Japan, has just been awarded conditional …
News
headquarters_3_web

Eli Lilly’s Emgality shows positive Phase 3 results in treatment of migraine

May 8, 2019 Research and Development Eli Lilly, Emgality, cluster headache, headache, migraine, pharma

Eli Lilly has announced positive results from the Phase 3 EVOLVE-1 and EVOLVE-2 trials looking into Emgality (galcanezumab-gnlm) for the …
News
astrazeneca-sign

AZ ends Calquence trial early after Phase 3 success in chronic lymphocytic leukaemia

May 8, 2019 Research and Development AstraZeneca, Calquence, pharma

AstraZeneca has unveiled new Phase 3 data on the efficacy of its Bruton tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) in …
News

US prescription drugs most expensive in world, analysis shows

May 8, 2019 Research and Development Drug pricing, Japan, Ontario, UK, US, prescription drugs

Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …
News

Number of GPs in decline for first time in 50 years

May 8, 2019 Manufacturing and Production, Research and Development GP, NHS, pharma, public health

The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall …
News
mohammed_dar

Mohammed Dar becomes third MedImmune exec to join Immunocore

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO. Dar …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026